MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-14-2026
Co-Diagnostics ROE Ratio 2011-2026 | CODX
Annual ROE Ratio Co-Diagnostics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -227.33 | -69.86 | -41.29 | -12.43 | 27.26 | 63.69 | -356.63 | 592.34 | -180.73 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 592.34 | -356.63 | -22.78 |
Quarterly ROE Ratio Co-Diagnostics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -106.27 | -64.49 | -60.21 | -53.3 | -37.58 | -43.6 | -37.02 | -31.72 | -19.84 | -20.85 | -16.69 | -0.14 | 5.06 | 16.52 | 28.74 | 40.96 | 33.03 | 56.62 | 67.66 | 54.85 | 44.49 | -56.12 | -157.09 | -258.36 | -256.76 | -101.76 | 128.44 | 329.57 | 408.34 | 307.22 | 130.02 | -17.9 | -141.65 | -126.62 | -10.73 | -18.33 | - | 15.03 | 14.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 408.34 | -258.36 | 1.17 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 201.41 | -0.81 % | $ 22.4 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 87.87 | -0.77 % | $ 4.11 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-5.44 | $ 18.82 | 0.74 % | $ 579 M | USA |
 |
Castle Biosciences
CSTL
|
-5.13 | $ 20.98 | 1.35 % | $ 608 M | USA |
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.64 | 2.19 % | $ 7.26 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
419.21 | $ 132.35 | 0.55 % | $ 16.6 B | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 23.83 | 3.74 % | $ 1.27 B | USA |
 |
Illumina
ILMN
|
31.22 | $ 166.13 | 3.21 % | $ 25.8 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
2.49 | $ 147.98 | 1.23 % | $ 11.6 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 161.11 | 2.62 % | $ 23.9 B |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-147.83 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
-12.91 | $ 11.21 | 0.54 % | $ 1.44 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 18.77 | -0.11 % | $ 420 M | USA |
 |
Natera
NTRA
|
-12.16 | $ 216.16 | 1.93 % | $ 29.6 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 104.54 | 0.02 % | $ 7.06 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 190.24 | 1.46 % | $ 9.43 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.99 | $ 1.39 | 5.81 % | $ 417 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 468.22 | 0.19 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 4.32 | -0.23 % | $ 400 M | USA |
 |
Personalis
PSNL
|
-31.12 | $ 10.25 | 6.88 % | $ 915 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 26.74 | 1.06 % | $ 25.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 7.31 | 1.74 % | $ 305 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 81.92 | 7.55 % | $ 4.9 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.01 | -1.95 % | $ 4.62 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 264.57 | -0.6 % | $ 22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 474.8 | 1.26 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 0.67 | 2.52 % | $ 241 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.22 | 1.26 % | $ 2 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |